share_log

Key Takeaways From Surgery Partners Analyst Ratings

Key Takeaways From Surgery Partners Analyst Ratings

Surgery Partners分析師評級的要點
Benzinga ·  11/20 12:00  · 評級/大行評級
Analysts' ratings for Surgery Partners (NASDAQ:SGRY) over the last quarter vary from bullish to bearish, as provided by 7 analysts.
過去季度,7位分析師對Surgery Partners(納斯達克股票代碼:SGRY)的評級從看好到看淡不一。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中,您將找到他們最近的評級摘要,揭示了過去30天內情緒的變化,並將它們與前幾個月進行比較。
In the assessment of 12-month price targets, analysts unveil insights for Surgery Partners, presenting an average target of $38.43, a high estimate of $50.00, and a low estimate of $34.00. Observing a downward trend, the current average is 6.27% lower than the prior average price target of $41.00.
在12個月價格目標的評估中,分析師揭示了對Surgery Partners的見解,提出了平均目標價38.43美元,最高估值50.00美元,最低估值34.00美元。觀察到一個下降趨勢,當前平均價格比之前的目標價41.00美元低了6.27%。
Diving into Analyst Ratings: An In-Depth Exploration
深入探討分析師評級:分析師評級的深度探討
The...
通...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論